Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$1.69 - $2.79 $27,060 - $44,673
-16,012 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$2.68 - $4.85 $15,948 - $28,862
5,951 Added 59.15%
16,012 $46,000
Q2 2019

Aug 14, 2019

BUY
$5.15 - $7.92 $51,814 - $79,683
10,061 New
10,061 $80,000

Others Institutions Holding MRKR

About Marker Therapeutics, Inc.


  • Ticker MRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,599,200
  • Market Cap $206M
  • Description
  • Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...
More about MRKR
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.